相似文献
1
Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. Quo vadis?
Arch Pathol Lab Med. 2003 Jan;127(1):102-5. doi: 10.5858/2003-127-102-TDMIHI.
2
[AIDS triple therapy. The gap between viral load and side effects].
Fortschr Med. 1998 Sep 30;116(27):4-5.
3
Improvement in CD4+ cell counts despite persistently detectable HIV load.
N Engl J Med. 1998 Apr 9;338(15):1074-5. doi: 10.1056/NEJM199804093381517.
4
[Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].
MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:72-3.
5
[Antiviral therapy: when to begin, which goals should be set, what must be kept in mind? Tips for nonspecialists].
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:10-1.
6
Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.
Clin Diagn Lab Immunol. 2000 May;7(3):412-6. doi: 10.1128/CDLI.7.3.412-416.2000.
7
Starting, stopping, picking, and switching antiretrovirals or, the ring in the river. Glasgow: Part 2.
IAPAC Mon. 2001 Feb;7(2):54-66.
8
AIDS freak-time to give up?
Hopkins HIV Rep. 2001 Nov;13(6):11.
9
Therapies. Confronting the limits of success.
Science. 2002 Jun 28;296(5577):2320-4. doi: 10.1126/science.296.5577.2320.
10
Antiretroviral therapy for human immunodeficiency virus disease: implications for critical care nursing.
Crit Care Nurse. 1998 Dec;18(6):54-62.
引用本文的文献
1
The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury.
Toxicol Sci. 2024 Jun 26;200(1):146-164. doi: 10.1093/toxsci/kfae054.
2
The Structure-To-Function Relationships of Gammaherpesvirus-Encoded Long Non-Coding RNAs and Their Contributions to Viral Pathogenesis.
Noncoding RNA. 2018 Sep 26;4(4):24. doi: 10.3390/ncrna4040024.
3
Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients.
Antimicrob Agents Chemother. 2009 Jul;53(7):2791-8. doi: 10.1128/AAC.01537-08. Epub 2009 May 11.
4
Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy.
Clin Pharmacokinet. 2005;44(6):591-625. doi: 10.2165/00003088-200544060-00003.
本文引用的文献
1
The economics of HIV in Africa.
Lancet. 2002 Jul 6;360(9326):1.
2
High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Ther Drug Monit. 2002 Jun;24(3):417-24. doi: 10.1097/00007691-200206000-00015.
3
Critical issues in therapeutic drug monitoring of antiretroviral drugs.
Ther Drug Monit. 2002 Jun;24(3):323-31. doi: 10.1097/00007691-200206000-00001.
4
Simple rapid method for quantification of antiretrovirals by liquid chromatography-tandem mass-spectrometry.
Clin Biochem. 2002 Mar;35(2):99-103. doi: 10.1016/s0009-9120(02)00286-2.
5
Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.
AIDS. 2002 Mar 8;16(4):551-60. doi: 10.1097/00002030-200203080-00006.
6
Review: therapeutic drug monitoring in pediatrics.
Ther Drug Monit. 2002 Feb;24(1):1-8. doi: 10.1097/00007691-200202000-00001.
7
Pharmacokinetic and other drug interactions in patients with AIDS.
Ther Drug Monit. 2001 Dec;23(6):591-605. doi: 10.1097/00007691-200112000-00001.
8
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Ther Drug Monit. 2001 Aug;23(4):380-8. doi: 10.1097/00007691-200108000-00010.
9
Clinical Pharmacologic Considerations for HIV-1 Protease Inhibitors.
Curr Infect Dis Rep. 2001 Aug;3(4):381-387. doi: 10.1007/s11908-001-0079-3.
10
Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry.
Clin Biochem. 2001 Jun;34(4):285-90. doi: 10.1016/s0009-9120(01)00235-1.
Zotero 插件